Ransom Advisory Ltd purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 895 shares of the healthcare conglomerate's stock, valued at approximately $469,000.
A number of other institutional investors and hedge funds also recently bought and sold shares of UNH. Brighton Jones LLC increased its stake in shares of UnitedHealth Group by 176.2% during the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after buying an additional 28,231 shares during the period. Revolve Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 137.1% during the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after buying an additional 2,324 shares during the period. Gotham Asset Management LLC increased its stake in shares of UnitedHealth Group by 11.8% during the fourth quarter. Gotham Asset Management LLC now owns 18,741 shares of the healthcare conglomerate's stock worth $9,480,000 after buying an additional 1,980 shares during the period. NDVR Inc. increased its stake in shares of UnitedHealth Group by 5.7% during the fourth quarter. NDVR Inc. now owns 681 shares of the healthcare conglomerate's stock worth $344,000 after buying an additional 37 shares during the period. Finally, Morse Asset Management Inc increased its holdings in shares of UnitedHealth Group by 2.1% in the 4th quarter. Morse Asset Management Inc now owns 17,964 shares of the healthcare conglomerate's stock valued at $9,087,000 after acquiring an additional 371 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Performance
Shares of NYSE UNH traded up $7.11 during midday trading on Thursday, reaching $353.89. 18,916,413 shares of the company were exchanged, compared to its average volume of 19,187,298. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The stock has a fifty day simple moving average of $291.11 and a 200 day simple moving average of $370.48. The stock has a market cap of $320.51 billion, a P/E ratio of 15.33, a PEG ratio of 2.27 and a beta of 0.45.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the prior year, the business earned $6.80 EPS. The business's quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.
Analysts Set New Price Targets
UNH has been the topic of a number of recent analyst reports. Mizuho dropped their price objective on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a report on Friday, May 16th. Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. JPMorgan Chase & Co. dropped their price objective on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Finally, Oppenheimer reduced their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $355.77.
Check Out Our Latest Research Report on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.